<?xml version="1.0" encoding="UTF-8"?>
<p id="Par57">ADAM9, EFNB2, MET, TMOD3, TPX2 and WNT7A are potential PAAD antigens for mRNA vaccine development. Patients with immune subtypes 4 and 5 are suitable candidates for vaccination. Our findings provide a theoretical basis for developing anti-PAAD mRNA vaccine, predicting patient prognosis and selecting patients for vaccination.</p>
